Allergies environmental
Drug research and approvals for allergies environmental: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 18 studies of allergies environmental are recruiting on ClinicalTrials.gov, and Health Canada has authorized 14 drug trials for it since 2013.
- Recruiting worldwide: 18
- Trials authorized in Canada: 14
- FDA orphan approvals: 0
- EU medicines: 0
Newest posted first, of 18 recruiting on ClinicalTrials.gov ↗
- Chronic Respiratory Disease Participant Engagement StudyNCT07924462 · Not reported · Richmond Research Institute · starts Nov 1, 2026
- Lungs on Fire: Wildfire Smoke, Incident Diseases, Susceptible Populations, and Community Values in CanadaNCT07536178 · Not applicable · University of British Columbia · starts May 26, 2026
- Can Astaxanthin Help Manage Asthma in POlluted Areas?NCT07507682 · Not applicable · Middlesex University · starts May 15, 2026
- Advancing Diagnosis and Treatment of Pediatric AsthmaNCT07500246 · Not applicable · Luxembourg Institute of Health · starts Jan 2, 2026
- Humidity Asthma Interventions for Low Socioeconomic Status ChildrenNCT07453667 · Not applicable · Case Western Reserve University · starts May 2, 2026
- Effects of Environmental Fungal Exposure on Bronchial Asthma, ABPA and BronchiectasisNCT07313904 · Not reported · First Affiliated Hospital of Ningbo University · starts Jul 23, 2025
- Microbiome and Atopy in MaliNCT07051902 · Not reported · National Institute of Allergy and Infectious Diseases (NIAID) · starts Sep 30, 2025
- Reprogramming Energy Homeostasis in Overweight Individuals Via Exercise, Cognitive, and Social TrainingNCT06931730 · Not applicable · Bambino Gesù Hospital and Research Institute · starts Feb 8, 2024
- Validation of the Efficacy of Air Purifiers in Indoor Environment and Allergic Symptoms in Allergic Rhinitis PatientsNCT06890572 · Not applicable · Yonsei University · starts Mar 11, 2025
The 10 newest of 14; search them all in Canada trials
| Jun 18, 2015 | "a randomized, double-blind, placebo-controlled, multi-center study of the efficacy and safety of STG320 sublingual tablets of house dust mite (HDM) allergen…STG320 hdm sublingual tablets | Stallergenes S.A. | Ongoing |
| May 28, 2015 | "the impact of grass slit treatment on birch pollen induced allergic rhinitis - a pilot evaluation. "Grastek (standardized timothy grass pollen) | Kingston General Hospital | Ongoing |
| Apr 17, 2015 | "a dose-response evaluation of the sq tree slit-tablet in subjects with moderate to severe allergic rhinoconjunctivitis induced by pollens from the birch group…Sq tree slit-tablet | ALK-Abelló | Closed |
| Apr 8, 2015 | An observational follow-on field study to evaluate the continued efficacy and safety of ragweed-spire treatment in ragweed allergic subjects approximately one…Ragweed-spire | Circassia Pharmaceuticals | Closed |
| Oct 15, 2014 | A phase IV, open-label, safety and tolerability trial of MK-3641 and MK-7243 co-administered in subjects at least 18 years of age with ragweed and grass pollen…Grastek, Ragwitek | Merck & Co. (MSD) | Ongoing |
| Sep 11, 2014 | A double-blind, randomized, placebo-controlled, multi-centre field study to assess the efficacy and safety of hdm-spire in subjects with a history of house…Hdm-spire (toleromune house dust mite) | Circassia Pharmaceuticals | Ongoing |
| Aug 21, 2014 | A double-blind, placebo-controlled, randomized trial to compare the efficacy and tolerability of three dose regimens of allert, a combination of contiguous…Allert | Anergis S.A. | Ongoing |
| Aug 8, 2014 | Double-blind, placebo-controlled randomized trial to study the viaskin milk efficacy and safety for treating ige-mediated cow's milk allergy in childrenViaskin milk (DBV135) | DBV Technologies | Closed |
| Mar 28, 2014 | A multi-centre, double-blind, randomised, placebo-controlled parallel-group study to assess the safety and tolerability of grass-spire in subjects with asthma…Grass-spire (toleromune grass) | Circassia Pharmaceuticals | Ongoing |
| Jan 29, 2014 | A single center, randomized, double-masked, placebo-controlled, parallel group study to assess the efficacy and safety of EBI-005 topical ophthalmic solution…EBI-005 | Eleven Biotherapeutics | Ongoing |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA